1. Home
  2. MKSI vs BLCO Comparison

MKSI vs BLCO Comparison

Compare MKSI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKSI
  • BLCO
  • Stock Information
  • Founded
  • MKSI 1961
  • BLCO 1853
  • Country
  • MKSI United States
  • BLCO Canada
  • Employees
  • MKSI N/A
  • BLCO N/A
  • Industry
  • MKSI Industrial Machinery/Components
  • BLCO Ophthalmic Goods
  • Sector
  • MKSI Industrials
  • BLCO Health Care
  • Exchange
  • MKSI Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • MKSI 7.6B
  • BLCO 6.3B
  • IPO Year
  • MKSI 1999
  • BLCO 2022
  • Fundamental
  • Price
  • MKSI $103.09
  • BLCO $15.77
  • Analyst Decision
  • MKSI Buy
  • BLCO Buy
  • Analyst Count
  • MKSI 12
  • BLCO 12
  • Target Price
  • MKSI $140.08
  • BLCO $19.82
  • AVG Volume (30 Days)
  • MKSI 946.6K
  • BLCO 751.8K
  • Earning Date
  • MKSI 02-12-2025
  • BLCO 02-19-2025
  • Dividend Yield
  • MKSI 0.85%
  • BLCO N/A
  • EPS Growth
  • MKSI N/A
  • BLCO N/A
  • EPS
  • MKSI 2.81
  • BLCO N/A
  • Revenue
  • MKSI $3,586,000,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • MKSI $9.37
  • BLCO $17.29
  • Revenue Next Year
  • MKSI $8.82
  • BLCO $5.47
  • P/E Ratio
  • MKSI $36.69
  • BLCO N/A
  • Revenue Growth
  • MKSI N/A
  • BLCO 15.56
  • 52 Week Low
  • MKSI $97.54
  • BLCO $13.16
  • 52 Week High
  • MKSI $147.40
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • MKSI 39.08
  • BLCO 32.89
  • Support Level
  • MKSI $102.40
  • BLCO $15.62
  • Resistance Level
  • MKSI $110.47
  • BLCO $16.60
  • Average True Range (ATR)
  • MKSI 3.68
  • BLCO 0.46
  • MACD
  • MKSI -0.75
  • BLCO -0.05
  • Stochastic Oscillator
  • MKSI 8.87
  • BLCO 7.01

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: